Findings from studies on whole-genome and the exome sequencing of 243 human liver tumors identified the TP53 (Trp53 in mice; short p53) as the most commonly mutated tumor suppressor gene in HCC samples and the p53 pathway being affected in half of HCC patients4–6. This evidence concerns the gene TP53 and hepatocellular carcinoma.